Caris Life Sciences, Inc. (CAI) Revenue History
Annual and quarterly revenue from 2013 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
CAI Revenue Analysis (2013–2025)
As of March 5, 2026, Caris Life Sciences, Inc. (CAI) generated trailing twelve-month (TTM) revenue of $812.0 million. The most recent quarter (Q4 2025) recorded $292.9 million in revenue, up 35.1% sequentially.
Looking at the longer-term picture, CAI's 5-year compound annual growth rate (CAGR) stands at +22.5%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $812.0 million in 2025, representing a new all-time high.
When compared to Healthcare sector peers including VCYT (+16.0% YoY), ADPT (+42.6% YoY), and CDIO (-55.8% YoY). Compare CAI vs VCYT →
Peer Comparison
Compare CAI's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CAICurrent | $812M | - | +22.5% | 5.6% | |
 VCYT | $517M | +16.0% | +34.5% | 11.2% | |
 ADPT | $179M | +42.6% | +16.0% | -90.8% | |
 CDIO | $34,890 | -55.8% | - | -23977.9% | |
 SEER | $14M | +14.5% | +160.6% | -717.7% | |
 IMDX | $2M | +520.9% | - | -3245.1% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $812.0M | +97.0% | $0 | - | $45.1M | 5.6% |
| 2024 | $412.3M | +34.7% | $178.8M | 43.4% | $-257,122,000 | -62.4% |
| 2023 | $306.1M | +18.4% | $89.3M | 29.2% | $-319,551,000 | -104.4% |
| 2022 | $258.5M | -12.1% | $80.0M | 31.0% | $-315,756,000 | -122.2% |
| 2020 | $294.0M | -29.4% | $184.2M | 62.6% | $139.1M | 47.3% |
| 2019 | $416.5M | -3.6% | $200.5M | 48.1% | $130.3M | 31.3% |
| 2018 | $432.1M | +24.0% | $213.6M | 49.4% | $148.8M | 34.4% |
| 2017 | $348.4M | +18.4% | $169.3M | 48.6% | $105.7M | 30.3% |
| 2016 | $294.4M | +17.9% | $137.5M | 46.7% | $66.0M | 22.4% |
| 2015 | $249.7M | +9.7% | $125.9M | 50.4% | $68.1M | 27.3% |
See CAI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CAI Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare CAI vs LLY
See how CAI stacks up against sector leader Eli Lilly and Company.
Start ComparisonFrequently Asked Questions
Is CAI's revenue growth accelerating or slowing?
CAI TTM revenue: $812M. YoY growth: N/A. 5-year CAGR: +22.5%.
What is CAI's long-term revenue growth rate?
Caris Life Sciences, Inc.'s 5-year revenue CAGR of +22.5% reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is CAI's revenue distributed by segment?
CAI reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2025 are available for download. Segment mix reveals concentration and diversification trends.